|
|
||||||||
Radiology, Vol 150, 327-330, Copyright © 1984 by Radiological Society of North America
ARTICLES |
LK Olson, JV Forrest, PJ Friedman, PE Kiser and CI Henschke
Amiodarone (Cordarone) is an antiarrhythmic cardiac drug that is currently being evaluated in the United States. Pulmonary infiltrates developed in six of 34 patients who were receiving amiodarone in daily doses of 200-800 mg over a period of 1.5 to 12 months. Two patients died, one returned to normal after amiodarone had been discontinued for six months, and three have residual radiographic abnormalities (two continue to receive amiodarone with steroids). Radiologists should be aware of the history of amiodarone therapy and this possible serious side effect so that they can detect the earliest changes in the lung.
This article has been cited by other articles:
![]() |
M. C. Ott, A. Khoor, J. P. Leventhal, T. E. Paterick, and C. D. Burger Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone Chest, February 1, 2003; 123(2): 646 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Poll, P. May, J.-A. Koch, G. Hetzel, P. Heering, and U. Modder HRCT Findings of Amiodarone Pulmonary Toxicity: Clinical and Radiologic Regression Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 307 - 311. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |